65,437 trials
Stable Angina
Primary: PRU(Platelet Rreactivity Unit) 24 Hours After DAPT(Dual AntiPlatelet Therapy) Western Blot After Medication — 148; 289; 79; 132 PRU(Platelet Rreactivity Unit)
Alcoholism
Primary: Biphasic Alcohol Effects Scale:Total Mood — 6.94; 3.57; 6.50; 3.20 units on a scale
Nonproliferative Diabetic Retinopathy
Primary: Percentage of Participants Who Improved by ≥2 Steps From Baseline in the Diabetic Retinopathy Disease Severity Scale (DRSS) Score at Week 24 in the Combined 2Q16 and 2Q8…
Oropharyngeal Cancer · Squamous Cell Carcinoma to the Head and Neck
Primary: Average/Cumulative Opioid Dose — 32.65306; 31.60714 mg
Stroke
Primary: Change in Behavioral Intent to Call 911 — 2.1; 0.4 units on a scale
Second Hand Tobacco Smoke
Primary: Prevalence of Daily Exposure to Secondhand Smoke (SHS) in Indoor Settings — 2888 Participants
Autism · Aggression · Bipolar Disorder
Primary: Family Empowerment Scale — 3.75; 3.86; 3.81; 4.02 units on a scale — p=.15
Growth Hormone Deficiency
Primary: Number of Participants Classified According to Insulin-like Growth Factor (IGF-I) Assessments — 11; 2; 4; 63 Participants
Pterygium · Ocular Pain · Ocular Inflammation
Primary: Conjunctival Hyperemia (CH) — 0; 0; 39; 29 eyes — p=0.133
Intimate Partner Violence
Primary: Change in Dating Violence (DV) Perpetration From Baseline to 9 Months — 46; 40; 14; 14 Participants
Non-Small Cell Lung Cancer · Lung Cancer
Primary: Time To First Disease Progression — 14 Month
Diabetes Mellitus, Type 2 · Diabetic Nephropathy
Primary: Primary Composite Endpoint of Doubling of Serum Creatinine (DoSC), End-stage Kidney Disease (ESKD), and Renal or Cardiovascular (CV) Death — 61.24; 43.21 Event rate per…
Traumatic Brain Injury · Hopelessness · Suicide
Primary: Beck Hopelessness Scale (BHS) — 9.2; 12.6; 9.8; 8.9 score on a scale — p=.03
Short Bowel Syndrome
Primary: Stage 2: Absolute Change From Baseline in Weekly Parenteral Support (PS) Volume at Week 24 — -4.92 Liter per week (L/week)
Transplantation
Primary: Number of Participants With Acute Rejection — 256; 37 participants